About Aligo Innovation
Aligo Innovation is a venture capital firm founded in 2001. It is primarily based out of Montreal, Canada. As of Oct 2018, Aligo Innovation has invested in 23 companies. It primarily invests in Series A round in Canada based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Series A round of Laurent Pharma Overall, Aligo Innovation portfolio has seen 1 IPO and 3 acquisitions, namely Milestone Pharmaceuticals and Noviflow. A lot of funds co-invest with Aligo Innovation, with names like Anges Quebec sharing a substantial percentage of its portfolio.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed & Series A
Portfolio IPOs
Aligo Innovation's List of Top Investments
Aligo Innovation has a portfolio of 23 companies. Their most notable investments include Milestone Pharmaceuticals and Noviflow.Their portfolio spans across Canada and United States. They have invested in Life Sciences, High Tech, Enterprise Applications and 5 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by Aligo Innovation:Provider of small molecule based drug development for treating cardio vascular conditions. The company's lead product is a novel and potent short-acting calcium channel antagonist for the systemic treatment of transient cardiovascular conditions such as atrial arrhythmias and angina. The product is being developed as a nasal spray to provide for rapid systemic drug delivery.
Key facts about Milestone Pharmaceuticals
- Founded Year: 2005
- Location: Montreal (Canada)
- Annual Revenue: $1M - $10M as on Dec 31, 2022
- Stage: Public
- Total Funding till date: $175M
- Employee Count: 129 as on Sep 30, 2026
- Investors: RTW Investments, Boxer Capital and 15 Others
- Latest Funding Round: Post IPO, Mar 28, 2023, $*****
- Highlight: Public
2. Noviflow
Provider of a platform offering network monitoring solutions. It provides high performance OpenFlow based switching solutions to data centers and network operators seeking greater control and flexibility over their networks. In December 2012 NoviFlow launched a high-performance OpenFlow switch, the NoviKit 100, and was listed by Business Insider as one of the eight SDN startups to watch in 2013. NoviFlow has offices in Sunnyvale, Montreal, and Seattle.
Key facts about Noviflow
- Founded Year: 2012
- Location: Montreal (Canada)
- Stage: Acquired
- Total Funding till date: $9M
- Employee Count: 12 as on Sep 30, 2026
- Investors: Plug and Play Tech Center, Canadian Technology Accelerator and 4 Others
- Latest Funding Round: Series A, Sep 10, 2015, $*****
- Highlight: Acquired
3. AngioChem
AngioChem is a clinical-stage biotechnology company that develops small molecule drugs that treat neurological diseases. The company claims its Engineered Peptide Compounds (EPiC) platform helps in developing drugs that use a receptor-based approach for crossing the blood-brain barrier. The company is developing a Phase III study for its lead product, ANG1005. It is a paclitaxel-peptide drug conjugate used for breast cancer patients with leptomeningeal carcinomatosis, a metastatic cancer that spreads rapidly to the membranes of the brain and spinal cord
Key facts about AngioChem
- Founded Year: 2003
- Location: Montreal (Canada)
- Stage: Series C
- Total Funding till date: $13.5M
- Employee Count: 12 as on Jul 01, 2024
- Investors: MMV Financial, Gouv Qc and 3 Others
- Latest Funding Round: Conventional Debt, Jun 04, 2019, $*****
- Highlight: Editors' Pick
4. Emovi
KneeKG has developed a knee assessment device. The KneeKG device is used for providing the data and insight on the movement of the knee joints, biochemical markers, gait impairment or alteration and cause of the knee pain. Based on the knee kinematics, data-driven, personalized therapies are provided.
Key facts about Emovi
- Founded Year: 2007
- Location: Montreal (Canada)
- Stage: Series C
- Total Funding till date: $11.3M
- Employee Count: 44 as on Sep 30, 2026
- Investors: Desjardins, StandUp Ventures and 4 Others
- Latest Funding Round: Conventional Debt, Mar 05, 2019, $*****
- Highlight: Editors' Pick
Soundbite Medical develops shockwave device and generator technology delivered within the cardiovascular system to treat chronic total occlusions. The company's products will target CTO’s in patients with peripheral artery disease (PAD) and coronary artery disease (CAD). A sound wave passing through a guidewire acts like a pneumatic drill, piercing the plaque and freeing up space in the artery. It frees up blood vessels blocked by atherosclerotic plaque. As of July 2016, The Soundbite crossing system is not FDA approved and is not for sale in, or outside, the United States
Key facts about Soundbite Medical
- Founded Year: 2013
- Location: Montreal (Canada)
- Stage: Series A
- Total Funding till date: $22.3M
- Employee Count: 3 as on Aug 31, 2026
- Investors: Fidelity, MBX Capital and 5 Others
- Latest Funding Round: Series A, Apr 23, 2018, $*****
Aligo Innovation's Year-on-Year Investment Trends
Aligo Innovation has invested in 23 companies over the last 10 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in NexPlasmaGen and most recent follow-on round was in Laurent Pharma.Aligo Innovation's Investments by Stage
Aligo Innovation has made 2 investments in Seed stage with an average round size of $1.09M and 2 investments in Series A stage with an average round size of $1.8M.Stage of entry | No. of Investments |
|---|---|
Seed | 2 |
Series A | 2 |
Note: We have considered here, only first round of investments
Aligo Innovation's Investments by Sector
Aligo Innovation has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Internet of Things - Industry Applications and Semiconductors. Notably, it has invested in 17 Tech companies, 16 Enterprise (B2B) companies, 7 Software companies and at least 5 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 3 |
High Tech | 2 |
Internet of Things - Industry Applications | 1 |
Semiconductors | 1 |
Note: We have considered here, only first round of investments
Aligo Innovation's Investments by Geography
Aligo Innovation has made most investments in Canada (3), followed by United States where it has made 1 investment.Country | No. of Investments |
|---|---|
Canada | 3 |
United States | 1 |
Note: We have considered here, only first round of investments
Aligo Innovation's recent investments
Aligo Innovation has not made any investment in 2026 so far.Here are the most recent investments by Aligo Innovation:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Oct 25, 2018 | Canada | Series A | 9180 | [+3] | |
Aug 13, 2018 | Canada | Seed | 1220 | [+2] | |
Sep 19, 2017 | United States | Seed | 5513 | ||
Mar 17, 2016 | Canada | Series A | 1082 | [+1] | |
Feb 26, 2016 | Canada | Series A | 1128 | [+1] |
IPOs and Publicly Listed companies in Aligo Innovation's Portfolio
1 of Aligo Innovation's portfolio company became public - Milestone Pharmaceuticals. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in May 2019 at marketcap of $355MHere are Aligo Innovation's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 09, 2019 | - | - | 6168 |
Acquired companies in Aligo Innovation's Portfolio
3 companies from Aligo Innovation's portfolio have been acquired. The most recent acquisition was Noviflow in Oct 2024 by ECIN for $*****.Here are Aligo Innovation's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 30, 2024 | - | - | 9388 | |
Sep 17, 2021 | Feb 26, 2016 | Series A | 8003 | |
Nov 18, 2019 | - | - | 3599 |
Co-investors of Aligo Innovation
Over the past 10 years, 11 investors have co-invested in Aligo Innovation's portfolio companies. This includes only funds.
- Top Co-investors of Aligo Innovation: 7 investors entered a company along with Aligo Innovation. These include investors like Anges Quebec (2 companies).
- Invested after Aligo Innovation: A total of 4 investors have invested in Aligo Innovation's portfolio after their investments. Top Investors include Keiretsu Forum (1 company), RSJ (1 company) and Cystic Fibrosis Foundation (1 company).
Recent News related to Aligo Innovation
•
Laurent Pharmaceuticals Welcomes New Investors and Announces Scientific Breakthrough with LAU-7b in Cystic FibrosisPR Newswire•Oct 25, 2018•Laurent Pharma, Keiretsu Forum, Anges Quebec, RSJ and 2 others
•
Anges Québec and Aligo Innovation invest $1.38 million in Ovensa | Montreal in TechnologyMontreal in Technology•Sep 19, 2017•Ovensa, Anges Quebec, Aligo Innovation
•
Augmented Reality Computer Vision Startup Wrnch Gets $1.8M Series A Led By Mark Cuban – TechCrunchTechCrunch+•Feb 26, 2016•Wrnch, Aligo Innovation, TandemLaunch
•
SiXtron raises CDN $10M for thin film solar cell coatings | VentureBeatVentureBeat•Nov 07, 2007•Sixtron, Ventures West, Inovia Capital, Innova-Tech and 1 other
•
Resonant Medical Secures Largest Medical Device Venture Capital Financing In CanadaPR Newswire•Dec 15, 2005•Resonant Medical, Ventures West, MDS Capital, BDC and 3 others
•
•
•
